These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24533477)

  • 41. Angiogenic and antiangiogenic factors before and after resolution of maternal mirror syndrome.
    Llurba E; Marsal G; Sanchez O; Dominguez C; Alijotas-Reig J; Carreras E; Cabero L
    Ultrasound Obstet Gynecol; 2012 Sep; 40(3):367-9. PubMed ID: 22081513
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Placental origins of angiogenic dysfunction in mirror syndrome.
    Bixel K; Silasi M; Zelop CM; Lim KH; Zsengeller Z; Stillman IE; Rana S
    Hypertens Pregnancy; 2012; 31(2):211-7. PubMed ID: 22150085
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Modification of angiogenic factors by regular and acute exercise during pregnancy.
    Weissgerber TL; Davies GA; Roberts JM
    J Appl Physiol (1985); 2010 May; 108(5):1217-23. PubMed ID: 20224004
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The imbalance of circulating angiogenic/antiangiogenic factors is mild or absent in obese women destined to develop preeclampsia.
    Carbillon L
    Hypertens Pregnancy; 2014 Nov; 33(4):524. PubMed ID: 24842148
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparison of angiogenic and anti-angiogenic factors in maternal and umbilical cord blood in early- and late-onset pre-eclampsia.
    Sezer SD; Küçük M; Yenisey C; Yüksel H; Odabaşı AR; Türkmen MK; Çetinkaya Çakmak B; Ömürlü IK
    Gynecol Endocrinol; 2012 Aug; 28(8):628-32. PubMed ID: 22429154
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hypertension: Testing for pre-eclampsia: paving the way to early diagnosis.
    Benzing T
    Nat Rev Nephrol; 2016 Apr; 12(4):200-2. PubMed ID: 26923207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum markers for predicting pre-eclampsia.
    Baumann MU; Bersinger NA; Surbek DV
    Mol Aspects Med; 2007 Apr; 28(2):227-44. PubMed ID: 17532461
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Response to Carbillon L et al. letter titled; "The imbalance of circulating angiogenic/anti-angiogenic factors is mild or absent in obese women destined to develop preeclampsia".
    Rana S; Karumanchi SA
    Hypertens Pregnancy; 2014 Nov; 33(4):525. PubMed ID: 25068524
    [No Abstract]   [Full Text] [Related]  

  • 49. Biomarkers for the management of pre-eclampsia in pregnant women.
    Petla LT; Chikkala R; Ratnakar KS; Kodati V; Sritharan V
    Indian J Med Res; 2013; 138(1):60-7. PubMed ID: 24056556
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential diagnosis of preeclampsia: remember the soluble fms-like tyrosine kinase 1/placental growth factor ratio.
    Verdonk K; Visser W; Russcher H; Danser AH; Steegers EA; van den Meiracker AH
    Hypertension; 2012 Oct; 60(4):884-90. PubMed ID: 22892815
    [No Abstract]   [Full Text] [Related]  

  • 51. Screening for pre-eclampsia using serum placental growth factor and endoglin with Down's syndrome Quadruple test markers.
    Wald NJ; Bestwick JP; George LM; Wu T; Morris JK
    J Med Screen; 2012 Jun; 19(2):60-7. PubMed ID: 22547409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Approaching the threshold for predicting preeclampsia: monitoring angiogenic balance during pregnancy.
    Banek CT; Gilbert JS
    Hypertension; 2011 Nov; 58(5):774-5. PubMed ID: 21947465
    [No Abstract]   [Full Text] [Related]  

  • 53. First trimester serum angiogenic/anti-angiogenic status in twin pregnancies: relationship with assisted reproduction technology.
    Sánchez O; Llurba E; Marsal G; Domínguez C; Aulesa C; Sánchez-Durán MA; Goya MM; Alijotas-Reig J; Carreras E; Cabero L
    Hum Reprod; 2012 Feb; 27(2):358-65. PubMed ID: 22116949
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reply to: hepatic rupture - a rare but serious complication of HELLP syndrome.
    Schaarschmidt W; Stepan H
    J Perinat Med; 2014 Mar; 42(2):263-4. PubMed ID: 24413213
    [No Abstract]   [Full Text] [Related]  

  • 55. Insights into angiogenic imbalances during pregnancy.
    Espinoza J; Uckele JE; Starr RA; Lorenz RP; Bronsteen RA; Berry SM
    Obstet Gynecol; 2009 Aug; 114(2 Pt 2):437-440. PubMed ID: 19622952
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation between soluble endoglin, vascular endothelial growth factor receptor-1, and adipocytokines in preeclampsia.
    Masuyama H; Nakatsukasa H; Takamoto N; Hiramatsu Y
    J Clin Endocrinol Metab; 2007 Jul; 92(7):2672-9. PubMed ID: 17426083
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsia.
    Sandrim VC; Palei AC; Metzger IF; Gomes VA; Cavalli RC; Tanus-Santos JE
    Hypertension; 2008 Aug; 52(2):402-7. PubMed ID: 18574068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.
    Bolla D; Papadia A; Raio L
    N Engl J Med; 2016 May; 374(18):1785. PubMed ID: 27144855
    [No Abstract]   [Full Text] [Related]  

  • 59. The sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.
    Zeisler H; Hund M; Verlohren S
    N Engl J Med; 2016 May; 374(18):1785-6. PubMed ID: 27144854
    [No Abstract]   [Full Text] [Related]  

  • 60. Circular RNA in blood corpuscles combined with plasma protein factor for early prediction of pre-eclampsia.
    Zhang YG; Yang HL; Long Y; Li WL
    BJOG; 2016 Dec; 123(13):2113-2118. PubMed ID: 26846540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.